AI in Medicine News — 2026-10-19 (Mon) Evening News

Overview

Diagnostics and imaging moved most: two FDA clearances were reported, one for aortic measurement software and one for a breast cancer recurrence-risk tool, alongside several imaging studies and an ultrasound grant (Korea IT Times, Oncodaily, The Heights, Bioengineer.org). Operations and funding also moved: Healthleap's $38M raise and TechNovaTime's $3.4m raise were reported (Disrupt Africa, Launch Base Africa, Health Tech World). Policy news came from Korea on medical AI infrastructure.

Diagnostics and imaging

- Researchers in British Columbia were awarded a $3.2 million grant to develop AI-augmented ultrasound for neonatal health. The headline reports funding only, with no performance figures (The Heights). - Hybrid deep learning models are reported to sharpen breast cancer detection with ultrasound. The headline gives no accuracy figures and does not state the stage of evidence (Bioengineer.org). - A study is reported to find that AI spots hidden heart disease signals in ordinary chest X-rays. The headline gives no detection rate (Bioengineer.org). - Coreline Soft received its 13th FDA clearance, for AI-powered aortic measurement software (Korea IT Times). - The FDA cleared an AI tool to predict breast cancer recurrence risk before surgery. The headline does not name the product and gives no performance figures (Oncodaily).

Clinical decision support

- Sydney Children's Hospitals Network is preserving ICU data for future AI. This is data infrastructure, not a deployed model (Healthcare IT News). - AI models that predict radiation gut damage in cervical cancer are reported, under the question "Are They Ready for the Clinic?". The headline suggests clinical readiness is unresolved (Bioengineer.org). - An AI model estimates the individual effects of nursing care in cancer patients with heart risks. The headline gives no performance figures (Bioengineer.org). - An AI model combining ultrasound and digital breast tomosynthesis improves specificity in breast cancer triage. The headline gives no figures or study design (Bioengineer.org). - An article explains why there is no single AI for transplantation, saying two questions decode every algorithm (bioengineer.org). 【Generative AI and clinical documentation】 No headline addresses medical documentation or generative AI tools directly. - Healthleap, a clinical AI startup founded in South Africa, raised $38m in seed and Series A funding (Disrupt Africa). 【Hospital operations and care delivery】 - Launch Base Africa describes Healthleap's $38M as funding to scale AI that flags overlooked hospital conditions (Launch Base Africa). - TechNovaTime raised $3.4m to automate healthcare administration with AI (Health Tech World). - An Israeli hospital launched an AI system that gives a voice to children who cannot speak. The headline gives no evaluation data (THEJ.CA). - A listing titled "Hospital Throughput Command Center Artificial Intelligence" appeared. It is a press-release distribution item, and the headline gives no details (openPR.com). - A commentary argues that healthcare should pay attention to the "hidden fragility beneath the AI economy", using CoreWeave as its example (Distilled Post). 【Drug discovery and clinical trials】 No headline reports a preclinical or clinical-phase result. - Shridevi Institute and US-based Vaxonyx signed an MoU for AI-driven cancer and genomic research. This is an agreement, and the headline states no research stage (The Economic Times). - A Korean vice minister visited a NAVER data center to review medical AI infrastructure (Asiaeconomy). - Korea's health and welfare ministry proposed building a government data center to support medical AI and new drug development (Chosunbiz). 【Medical device approvals and regulation】 - Aortic measurement software from Coreline Soft: FDA clearance, its 13th (Korea IT Times). - An AI tool predicting breast cancer recurrence risk before surgery: FDA clearance. The product name is not given in the headline (Oncodaily). - No headline reports a designation or guidance.

Safety, errors and bias

- A feature says medical AI "gets real", from smart insulin pumps to robot surgeons. The headline cites no specific incidents or data (www.geneonline.com). - An article covers ethical challenges and responsibilities for doctors using AI in healthcare (InSight+). 【Research results (major journals)】 No headline comes from a major journal. - An AI platform is reported to allow real-time conversation between patients and their medical devices. The headline gives no evidence stage (Medical Xpress). - An article asks how to prevent an AI-created plague. It concerns biosecurity, and the headline gives no details (The Times).

Developments in Japan

- A press release titled "聞ける人がいない現場へ。“いつでも聞けるAI”が医療を変える" appeared. It was distributed via PR TIMES and carried by Mainichi Shimbun, and the headline gives no evidence of effect (Mainichi Shimbun). - GENSHI AI opened CARTE, a medical AI community for physicians and medical students, and began recruiting participants (PR TIMES). - Toyo Keizai reports on Taiwanese companies using AI and 3D printing for medical DX, positioned as responding to Japan's aging population and labor shortage (Toyo Keizai Online).

Statements by key figures

No notable developments.